Plain-English translation of NCT03718364 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a registry — a long-term tracking study — for people with atrial fibrillation who have had or are planning to have a catheter-based ablation procedure (also called pulmonary vein isolation). Researchers want to collect information from about 3,000 patients to understand how successful this heart rhythm procedure is in the long term and what factors help predict who benefits most from the treatment.
While catheter-based ablation is a well-established treatment for atrial fibrillation, doctors need more real-world data to understand how well it works for different patients over many years and what helps predict which patients will have the best outcomes.
You likely qualify if…
You likely don't qualify if…
You will be enrolled in this registry when you have your ablation procedure performed at a participating hospital. After that, the research team will track your health outcomes and collect information about your recovery and any recurrence of symptoms over the long term. This typically involves periodic follow-up visits or phone contacts to gather information about how you're doing.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
Switzerland
Sponsor
University Hospital, Basel, Switzerland
Enrollment target
~3,000 participants
Started
July 2010
Primary completion
December 2035
Age range
18 Years and older
Last updated on clinicaltrials.gov in February 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Michael Kuehne, MD
Cardiology/Electrophysiology, University Hospital Basel
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.